Home › Markets › Health Care › CDT

CDT Equity Inc. (CDT)

CDT trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$0.4500
-31.82% on the day
Market cap
$506K
Nano cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.

Profile

FieldValue
TickerCDT on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2022
SEC CIK0001896212
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

Not reported in SEC XBRL data.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32026-10-13
Latest annual report10-K2026-04-15
Latest quarterly / interim10-Q2026-08-12
Latest current report8-K2026-10-13
Latest proxyDEFA14A2026-08-12

Source: SEC EDGAR submissions feed, 357 recent filings. All filings on EDGAR.

Other listings for this company

TickerNamePrice
CDTTWCDT Equity Inc. Warrant$0.0056

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
SXTCChina SXT Pharmaceuticals Inc.$0.0774-24.12%$802K
BDRXBiodexa Pharmaceuticals plc American Depositary Shs$0.3502-8.61%$1.5M
ARTLArtelo Biosciences Inc.$2.98-4.18%$1.6M
LABTLakewood-Amedex Biotherapeutics Inc.$0.6939-5.08%$1.6M
OGENOragenics Inc.$0.4469-0.16%$2.0M
GNPXGenprex Inc.$2.51-6.69%$2.1M
SILOSilo Pharma Inc.$1.22-18.12%$2.1M
PPBTPurple Biotech Ltd.$1.36-1.45%$2.2M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier